REVIEWS REVIEWS reviews R RE REV REVI BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 0
VOL. 10 vol. V VO VOL VOL. BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .() 3 10 0 0 1 1 0
INTRODUCTION INTRODUCTION introduction I IN INT INTR BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 2 0 0 0 0 1
Uncontrolled aggregation uncontrolled U Un Unc Unco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
the formation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (- 2 8 0 0 0 0 1
teinopathy), is teinopathy), t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ), 2 9 0 0 0 0 1
many neurodegenerative many m ma man many BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 (), 3 8 0 0 0 0 1
amyotrophic lateral amyotrophic a am amy amyo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ().,- 5 9 0 0 0 0 1
opment of opment o op opm opme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
progression is progression p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
the development the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
from recent from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
obtained at obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 10 0 0 0 0 1
have convincingly have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
belongs to belongs b be bel belo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --(- 4 8 0 0 0 0 1
trepirdine) -to trepirdine) t tr tre trep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 )- 2 9 0 0 0 0 1
model proteinopathies model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
Our findings our O Ou Our Our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
its derivatives its i it its its BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
in model in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
Amyotrophic lateral amyotrophic A Am Amy Amyo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,- 2 9 0 0 0 0 1
rons, and rons, r ro ron rons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 ,- 2 9 0 0 0 0 1
gregation of gregation g gr gre greg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 . 1 9 0 0 0 0 1
pathogenic aggregation pathogenic p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 - 1 8 0 0 0 0 1
velopment of velopment v ve vel velo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
in numerous in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
the main the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
affecting motor affecting a af aff affe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 [-]. 4 9 0 0 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 , 1 8 0 0 0 0 1
most patients most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 . 1 9 0 0 0 0 1
Of particular of O Of Of Of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 - 1 8 0 0 0 0 1
and FUS and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 /-[-]. 6 8 0 0 0 0 1
mechanisms underlying mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
of these of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 , 1 9 0 0 0 0 1
motor neurons, motor m mo mot moto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,- 2 9 0 0 0 0 1
tein. There tein. t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 . 1 10 0 0 0 0 1
protein aggregation protein p pr pro prot BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
Gamma-Carbolines Derivatives gamma-carbolines G Ga Gam Gamm BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 - 1 8 0 1 0 0 1
Promising Agents promising P Pr Pro Prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 10 0 1 0 0 1
Pathogenic Therapy pathogenic P Pa Pat Path BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 9 0 1 0 0 1
V. I. v. V V. V. V. BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 ..,..,..*,..,,.., 17 10 0 0 0 0 1
V. L. v. V V. V. V. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 ..,,.., 7 3 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 0 0 0 1
Pirogov Russian pirogov P Pi Pir Piro BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 ,.,,,, 6 10 0 0 0 0 1
Russia Russia russia R Ru Rus Russ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 0 0 0 0 0 1
2 2 2 2 2 2 2 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 6 no 0 10 0 0 0 0 1
Institute of institute I In Ins Inst BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 ,., 3 10 0 0 0 0 1
Chernogolovka, 1142432, chernogolovka, C Ch Che Cher BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 ,, 2 3 0 0 0 0 1
3 3 3 3 3 3 3 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
Institute of institute I In Ins Inst BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 ,.,/,, 6 10 0 0 0 0 1
119334, Russia 119334, 1 11 119 1193 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 1 7 , 1 1 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 7 no 0 10 0 0 0 0 1
Cardiff University, cardiff C Ca Car Card BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 ,,,.,, 6 10 0 0 0 0 1
* * * * * * * BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 * 1 10 0 0 0 0 1
E-mail: alexey@ipac.ac.ru e-mail: E E- E-m E-ma BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 -:@.. 5 4 0 0 0 0 1
Received July received R Re Rec Rece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 ,;, 3 10 0 0 0 0 1
Copyright © copyright C Co Cop Copy BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 -,., 4 10 0 0 0 0 1
unrestricted use, unrestricted u un unr unre BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ,,,. 4 7 0 0 0 0 1
ABSTRACT Uncontrolled abstract A AB ABS ABST BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 ,, 2 9 0 0 0 0 1
component of component c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 9 0 0 0 0 1
intermediate products intermediate i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 . 1 10 0 0 0 0 1
pathogenic therapy pathogenic p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 no 0 10 0 0 0 0 1
progression and progression p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 .- 2 9 0 0 0 0 1
leading Russian leading l le lea lead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 (), 3 9 0 0 0 0 1
number of number n nu num numb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 -,- 3 9 0 0 0 0 1
ulate the ulate u ul ula ulat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 . 1 9 0 0 0 0 1
data indicate data d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 9 0 0 0 0 1
proteinopathies. proteinopathies. proteinopathies. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 8 . 1 1 0 0 0 0 1
KEYWORDS ALS, keywords K KE KEY KEYW BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 ,,-,,. 6 6 0 0 0 0 1
ABBREVIATIONS ALS abbreviations A AB ABB ABBR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 -;-;-; 6 9 0 0 0 0 1
TDP-43 -transactive tdp-43 T TD TDP TDP- BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 --. 3 5 0 0 0 0 1
60 | 60 6 60 60 60 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 .() 3 10 0 0 1 1 0
REVIEWS REVIEWS reviews R RE REV REVI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 0 1 0 0 0
pathogenesis of pathogenesis p pa pat path BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 1 0 0 1
target for target t ta tar targ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 7 0 1 0 0 1
NEUROPROTECTIVE PROPERTIES neuroprotective N NE NEU NEUR BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 4 0 0 0 0 1
OF GAMMA-CARBOLINES of O OF OF OF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 3 0 0 0 0 1
Data from data D Da Dat Data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
have demonstrated have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
gamma-carboline class gamma-carboline g ga gam gamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
agents leading agents a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 0 0 0 0 1
gregation and/or gregation g gr gre greg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 / 1 9 0 0 0 0 1
mechanisms of mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
proteins [7, proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 [,].-- 6 9 0 0 0 0 1
bolines properties bolines b bo bol boli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 - 1 8 0 0 0 0 1
ies showing ies i ie ies ies BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
patients with patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 '(), 4 9 0 0 0 0 1
most common most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 0 0 0 0 1
teinopathy group teinopathy t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 [,]., 5 9 0 0 0 0 1
conducted at conducted c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
effect from effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
tients with tients t ti tie tien BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 '[]., 5 9 0 0 0 0 1
clinical trials clinical c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 0 0 0 0 1
not considered not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
drugs for drugs d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 [], 3 9 0 0 0 0 1
most likely most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
nosological forms nosological n no nos noso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 '., 3 9 0 0 0 0 1
mechanisms of mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
proteinopathy progression proteinopathy p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
of intense of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 [].- 4 10 0 0 0 0 1
ample, the ample, a am amp ampl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 9 0 0 0 0 1
a positive a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
status indicators status s st sta stat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 [] 2 9 0 0 0 0 1
additional incentive additional a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
rection. In rection. r re rec rect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ., 2 9 0 0 0 0 1
of transgenic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
the development the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []. 3 9 0 0 0 0 1
key proteinopathy key k ke key key BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
bral amyloidosis, bral b br bra bral BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
in TgCRND8 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 [-]-[], 7 8 0 0 0 0 1
in a in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 - 1 8 0 0 0 0 1
sive course sive s si siv sive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 []. 3 9 0 0 0 0 1
grounds for grounds g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
gamma-carbolines effects gamma-carbolines g ga gam gamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 -- 2 8 0 0 0 0 1
er proteinopathies er e er er er BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
pathogenesis of pathogenesis p pa pat path BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 7 0 0 0 0 1
EFFECT OF effect E EF EFF EFFE BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 5 0 0 0 0 1
PROGRESSION OF progression P PR PRO PROG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 0 0 0 0 1
THE SPECIFIC the T TH THE THE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 7 0 0 0 0 1
Chronic administration chronic C Ch Chr Chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 0 0 0 0 1
mouse model mouse m mo mou mous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 8 0 0 0 0 1
gamma-synuclein which gamma-synuclein g ga gam gamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 - 1 8 0 0 0 0 1
of ALS of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 [,] 3 9 0 0 0 0 1
proteinopathy [23, proteinopathy p pr pro prot BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 [,].,- 6 10 0 0 0 0 1
cant decrease cant c ca can cant BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -- 2 9 0 1 0 0 1
soluble gamma-synuclein soluble s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 [] 2 8 0 1 0 0 1
decrease in decrease d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -- 2 9 0 1 0 0 1
affected spinal affected a af aff affe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
[21, 22]. [21, [ [2 [21 [21, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 [,].- 5 9 0 1 0 0 1
tion was tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 -,- 3 8 0 1 0 0 1
fore the fore f fo for fore BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 10 0 1 0 0 1
according to according a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
analysis. The analysis. a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 0 1 0 0 1
in SOD1 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 :- 2 8 0 1 0 0 1
tered long tered t te ter tere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
ALS phenotype-associated als A AL ALS ALS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 -, 2 8 0 1 0 0 1
of model of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 1 0 0 1
an increased an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 []., 4 9 0 1 0 0 1
Dimebon administration dimebon D Di Dim Dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 1 0 0 1
the drug the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 []. 3 8 0 1 0 0 1
confirmed the confirmed c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
inhibit proteinopathy inhibit i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -- 2 9 0 1 0 0 1
genic mouse genic g ge gen geni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 [,] 3 9 0 1 0 0 1
and represents and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 1 0 0 1
ment of ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 . 1 8 0 1 0 0 1
nervous system nervous n ne ner nerv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 1 0 0 1
FUS-associated forms fus-associated F FU FUS FUS- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 -, 2 8 0 1 0 0 1
analysis reveals analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 1 0 0 1
forms in forms f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 1 0 0 1
Both Dimebon both B Bo Bot Both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 1 0 0 1
with different with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,- 2 9 0 1 0 0 1
teinopathy in teinopathy t te tei tein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 9 0 1 0 0 1
[30]. For [30]. [ [3 [30 [30] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 []., 4 9 0 1 0 0 1
with Dimebon with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 .- 2 9 0 1 0 0 1
thermore, transfer thermore, t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ,- 2 9 0 1 0 0 1
C57Bl/6J genetic c57bl/6j C C5 C57 C57B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 /, 2 9 0 1 0 0 1
in most in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 ,-- 3 9 0 1 0 0 1
netic background netic n ne net neti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 -- 2 8 0 1 0 0 1
hibiting effect hibiting h hi hib hibi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 8 0 1 0 0 1
explained by explained e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 / 1 9 0 1 0 0 1
to gamma-carbolines to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -[]. 4 9 0 1 0 0 1
lifespan, the lifespan, l li lif life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,- 2 9 0 1 0 0 1
derivative were derivative d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
model disease model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
pronounced ALS pronounced p pr pro pron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
compounds was compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
proteinopathy [31]. proteinopathy p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 []., 4 8 0 1 0 0 1
of Dimebon of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 0 1 0 0 1
from biochemical from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 1 0 0 1
cultures and cultures c cu cul cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,- 2 8 0 1 0 0 1
titarget drug titarget t ti tit tita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
processes and processes p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 1 0 0 1
and other and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 1 0 0 1
[7]. [7]. [7]. [ [7 [7] [7]. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 []. 3 0 0 1 0 0 1
Particularly, Dimebon particularly, P Pa Par Part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 1 0 0 1
of receptors of o of of of BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,- 2 9 0 1 0 0 1
REVIEWS REVIEWS reviews R RE REV REVI BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 10 0 0 0 0 0
VOL. 10 vol. V VO VOL VOL. BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 .() 3 10 0 0 1 0 0
naling enzymes naling n na nal nali BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 [,-],- 6 9 0 0 0 0 1
drial activity drial d dr dri dria BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 [,]., 5 10 0 0 0 0 1
property of property p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
proteinopathy, lies proteinopathy, p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,- 2 9 0 0 0 0 1
lation of lation l la lat lati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 8 0 0 0 0 1
GAMMA-CARBOLINE-BASED INHIBITION gamma-carboline-based G GA GAM GAMM BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 -- 2 6 0 0 0 0 1
ACCUMULATION OF accumulation A AC ACC ACCU BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 6 0 0 0 0 1
PROTEIN INCLUSIONS protein P PR PRO PROT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 7 0 0 0 0 1
The ability the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
of pathogenic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
was first was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
M. Hasegawa's m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 .'.' 4 9 0 0 0 0 1
cultures producing cultures c cu cul cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 8 0 0 0 0 1
gating RNA-binding gating g ga gat gati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 --[,]. 6 8 0 0 0 0 1
effect was effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 9 0 0 0 0 1
demonstrated that demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 /- 2 9 0 0 0 0 1
rivatives to rivatives r ri riv riva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
FUS proteinopathy fus F FU FUS FUS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 9 0 0 0 0 1
uble protein uble u ub ubl uble BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
amount of amount a am amo amou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
(unpublished data). (unpublished ( (u (un (unp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (). 3 8 0 0 0 0 1
on various on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
these effects, these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 10 0 0 0 0 1
the activation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 0 0 0 0 1
bon-treated groups bon-treated b bo bon bon- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -[,-]. 6 5 0 0 0 0 1
CONCLUSION CONCLUSION conclusion C CO CON CONC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 2 0 1 0 0 1
The results the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 - 1 10 0 1 0 0 1
at leading at a at at at BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 10 0 1 0 0 1
demonstrated that demonstrated d de dem demo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 -- 2 8 0 1 0 0 1
boline series boline b bo bol boli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
progression of progression p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 10 0 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 2 , 1 9 0 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 - 1 9 0 1 0 0 1
es in es e es es es BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 . 1 9 0 1 0 0 1
proteins involved proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
considered as considered c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
developing pathogenic developing d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
diseases [43]. diseases d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 []., 4 9 0 1 0 0 1
evidence for evidence e ev evi evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 9 0 1 0 0 1
as promising as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 8 0 1 0 0 1
therapeutic agents therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 no 0 8 0 1 0 0 1
and efficacy, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 9 0 1 0 0 1
pathogenic therapy pathogenic p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 - 1 9 0 1 0 0 1
erative diseases. erative e er era erat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 . 1 3 0 1 0 0 1
The study the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 0 0 0 1
systems was systems s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 no 0 8 0 0 0 0 1
Science Foundation science S Sc Sci Scie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 (.--); 6 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 0 0 0 1
support of support s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 no 0 9 0 0 0 0 1
of Physiologically of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 () 2 7 0 0 0 0 1
(Federal Agency (federal ( (F (Fe (Fed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 ( 1 8 0 0 0 0 1
No. 0090-2017-0016) no. N No No. No. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 .--) 4 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 10 0 0 0 0 1
IPAC RAS ipac I IP IPA IPAC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 , 1 8 0 0 0 0 1
State Assignment state S St Sta Stat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 ( 1 9 0 0 0 0 1
registration number registration r re reg regi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 --) 3 9 0 0 0 0 1
research program research r re res rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 3 no 0 9 0 0 0 0 1
Academy of academy A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 " 1 8 0 0 0 0 1
biomedical technologies." biomedical b bi bio biom BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 ." 2 4 0 0 0 0 1
REFERENCES REFERENCES references R RE REF REFE BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 1 0 1 0 0 1
1. Skvortsova 1. 1 1. 1. 1. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ...,..,.., 10 9 0 1 0 0 1
A.P., Kovrazhkina a.p., A A. A.P A.P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ..,..,..,.., 12 8 0 1 0 0 1
Shelkovnikova T.A., shelkovnikova S Sh She Shel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ..,..//... 10 9 0 1 0 0 1
im. S.S. im. i im im. im. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .........-. 11 7 0 1 0 0 1
2. Bachurin 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ..,.,.,., 9 9 0 1 0 0 1
Kovrazhkina E., kovrazhkina K Ko Kov Kovr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 .,.,.. 6 8 0 1 0 0 1
// Zh. // / // // // BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 //.......... 12 9 0 1 0 0 1
№ 10. № № № № № BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 5 ... 3 2 0 1 0 0 1
3. Bachurin 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ..,.,.,., 9 9 0 1 0 0 1
Kovrazhkina E., kovrazhkina K Ko Kov Kovr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 .,.,. 5 8 0 1 0 0 1
V. // v. V V. V. V. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 .//.......... 13 9 0 1 0 0 1
№ 9. № № № № № BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 5 ... 3 1 0 1 0 0 1
4. Mackenzie 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ...,..,..,., 12 9 0 1 0 0 1
M., Cairns m., M M. M., M., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 .,..,..,..,.,- 14 8 0 1 0 0 1
art H., art a ar art art BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 5 .,.//.......-. 14 9 0 1 0 0 1
5. Neumann 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ..,..,..,.., 12 8 0 1 0 0 1
Micsenyi M.C., micsenyi M Mi Mic Mics BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ..,..,.,.,., 12 9 0 1 0 0 1
Clark C.M., clark C Cl Cla Clar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 5 ..,.//......-. 14 10 0 1 0 0 1
6. Scotter 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ...,..,..//. 12 9 0 1 0 0 1
2015. V. 2015. 2 20 201 2015 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 .....-. 7 4 0 1 0 0 1
7. Ustyugov 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ..,.,.//.. 10 9 0 1 0 0 1
2015. V. 2015. 2 20 201 2015 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 .....-. 7 4 0 1 0 0 1
8. Ustyugov 8. 8 8. 8. 8. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..,.,..,.., 11 8 0 1 0 0 1
Bachurin S.O., bachurin B Ba Bac Bach BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 ..,.//....:. 12 9 0 1 0 0 1
4/0929867323666160804122746. 4/0929867323666160804122746. 4/0929867323666160804122746. 4 4/ 4/0 4/09 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 8 /. 2 4 0 1 0 0 1
9. Bachurin 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..,.,.,., 9 8 0 1 0 0 1
Afanasiev A., afanasiev A Af Afa Afan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 .,.,.,., 8 9 0 1 0 0 1
S., Zefirov s., S S. S., S., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 .,.//.........-. 16 10 0 1 0 0 1
10. Doody 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ...,..,.,.., 12 9 0 1 0 0 1
P.S., Bachurin p.s., P P. P.S P.S. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 ..,..,.,..//. 13 9 0 1 0 0 1
2008. V. 2008. 2 20 200 2008 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 8 .....-. 7 5 0 1 0 0 1
11. Kieburtz 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..,..,..,-., 12 9 0 1 0 0 1
Deue L.M., deue D De Deu Deue BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 ..,..,.,..,- 12 8 0 1 0 0 1
man K., man m ma man man BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 8 .,.,.//...... 13 9 0 1 0 0 1
P. 154-160. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 .-. 3 1 0 1 0 0 1
12. Bharadwaj 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ...,..,.,., 11 9 0 1 0 0 1
G., Steele g., G G. G., G., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 .,..,.,.,..,. 13 9 0 1 0 0 1
// Transl. // / // // // BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 //...... 8 6 0 1 0 0 1
13. Bachurin 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ...,..,..//.. 13 9 0 1 0 0 1
Rev. 2017. rev. R Re Rev Rev. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 ......-. 8 5 0 1 0 0 1
14. Cano-Cuenca 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 .-.,-..,.//. 12 9 0 1 0 0 1
Alzheimers Dis. alzheimers A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 ......-. 8 6 0 1 0 0 1
15. Peters 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ...,-.,.., 10 8 0 1 0 0 1
A. Y., a. A A. A. A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 8 ..,..,..,., 11 8 0 1 0 0 1
V.L. // v.l. V V. V.L V.L. BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 ..//.......-. 13 8 0 1 0 0 1
62 | 62 6 62 62 62 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 .() 3 10 0 0 1 0 0
REVIEWS REVIEWS reviews R RE REV REVI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 10 0 1 0 0 0
16. Steele 16. 1 16 16. 16. BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,.//..... 12 9 0 1 0 0 1
P. 617-618. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .-. 3 1 0 1 0 0 1
17. Steele 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,..,.,.,., 13 10 0 1 0 0 1
Kim S.H., kim K Ki Kim Kim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 0 ..,..,..,.,., 13 10 0 1 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .//.......-. 12 9 0 1 0 0 1
18. Wang 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ..,..,.,.,., 12 9 0 1 0 0 1
Xie M., xie X Xi Xie Xie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 0 .,.,.,..//.- 12 9 0 1 0 0 1
ner. 2011. ner. n ne ner ner. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ....... 7 4 0 1 0 0 1
19. Perez 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,.,..,., 11 9 0 1 0 0 1
C.M., Counts c.m., C C. C.M C.M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,..,.,..//... 15 10 0 1 0 0 1
Pathophysiol. Pharmacol. pathophysiol. P Pa Pat Path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .......-. 9 8 0 1 0 0 1
20. Peters 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,.,.,., 10 9 0 1 0 0 1
Kukharsky M.S., kukharsky K Ku Kuk Kukh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,..,.,..,- 12 9 0 1 0 0 1
evtsev Y., evtsev e ev evt evts BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .,..,.//... 11 9 0 1 0 0 1
V. 36. v. V V. V. V. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ....-. 6 3 0 1 0 0 1
21. Ninkina 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ..,.,.,., 9 9 0 1 0 0 1
Putten H., putten P Pu Put Putt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .,..//...... 12 9 0 1 0 0 1
№ 10. № № № № № BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 0 ..-. 4 3 0 1 0 0 1
22. Peters 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,.,..,., 11 9 0 1 0 0 1
Keeling L., keeling K Ke Kee Keel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 0 .,.,-.,.., 10 8 0 1 0 0 1
Ninkina N. ninkina N Ni Nin Nink BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .//.......-. 12 9 0 1 0 0 1
23. Bachurin 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,..,.., 10 8 0 1 0 0 1
Peters O., peters P Pe Pet Pete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 0 .,.,..,.., 10 9 0 1 0 0 1
Alentov I.I., alentov A Al Ale Alen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,..,..//.. 12 9 0 1 0 0 1
2012. V. 2012. 2 20 201 2012 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 .....-. 7 4 0 1 0 0 1
24. Bachurin 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,..,., 9 9 0 1 0 0 1
T.A., Buchman t.a., T T. T.A T.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,..,..//..- 13 8 0 1 0 0 1
phys. 2009. phys. p ph phy phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .....-. 7 5 0 1 0 0 1
25. Ustyugov 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,..,.., 10 8 0 1 0 0 1
Khritankova I. khritankova K Kh Khr Khri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,.,..,.., 11 9 0 1 0 0 1
Ninkina N.N. ninkina N Ni Nin Nink BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..//........ 12 9 0 1 0 0 1
P. 731-733. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .-. 3 1 0 1 0 0 1
26. Coughlan 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,..,..,..// 14 9 0 1 0 0 1
Neurobiol. Aging. neurobiol. N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .......-. 9 8 0 1 0 0 1
27. Tesla 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ..,..,.,.,.., 13 9 0 1 0 0 1
Huntington P., huntington H Hu Hun Hunt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 0 .,.,.,., 8 8 0 1 0 0 1
S., et s., S S. S., S., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .,.//......... 14 10 0 1 0 0 1
P. 17016-17021. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .-. 3 2 0 1 0 0 1
28. Shelkovnikova 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,..,..,- 11 8 0 1 0 0 1
nor-Robson N., nor-robson n no nor nor- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 -.,.,..,.., 11 9 0 1 0 0 1
Ermolkevich T.G., ermolkevich E Er Erm Ermo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,..,..,.//. 13 10 0 1 0 0 1
Biol. Chem. biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .......-. 9 7 0 1 0 0 1
29. Deikin 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...,..,..,- 11 9 0 1 0 0 1
vitskii E. vitskii v vi vit vits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,..,.., 9 9 0 1 0 0 1
T.G., Eliakov t.g., T T. T.G T.G. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..,..,..,..,.//. 16 9 0 1 0 0 1
Nevrol. Psikhiatr. nevrol. N Ne Nev Nevr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .......... 10 9 0 1 0 0 1
P. 62-69. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .-. 3 1 0 1 0 0 1
30. Bronovitsky 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,..,.., 10 9 0 1 0 0 1
A.B., Fedorov a.b., A A. A.B A.B. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,..,..,- 13 9 0 1 0 0 1
nikov R.K., nikov n ni nik niko BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,..,.//. 13 9 0 1 0 0 1
Biochem. Biophys. biochem. B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ......-. 8 6 0 1 0 0 1
31. Maltsev 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,..,.., 10 9 0 1 0 0 1
M.M., Kovrazhkina m.m., M M. M.M M.M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,.., 9 8 0 1 0 0 1
E. V., e. E E. E. E. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,..,..,.// 15 10 0 1 0 0 1
Zh. Nevrol. zh. Z Zh Zh. Zh. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ........... 11 9 0 1 0 0 1
P. 64-67. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .-. 3 1 0 1 0 0 1
32. Schaffhauser 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ..,..,., 8 9 0 1 0 0 1
M.J., Lu m.j., M M. M.J M.J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,..,.,..//- 16 8 0 1 0 0 1
chem. Pharmacol. chem. c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .......-. 9 7 0 1 0 0 1
33. Wu 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ..,.,.//... 11 9 0 1 0 0 1
V. 3. v. V V. V. V. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .... 4 2 0 1 0 0 1
34. Wang 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,..,..//.... 15 9 0 1 0 0 1
V. 734. v. V V. V. V. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ...-. 5 2 0 1 0 0 1
35. Weisova 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ..,..,..,., 11 9 0 1 0 0 1
Baumann B., baumann B Ba Bau Baum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 .,.,.,.., 9 8 0 1 0 0 1
H., Prehn h., H H. H., H., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .,..//...... 12 8 0 1 0 0 1
36. Zhang 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ..,.,..,.,- 11 9 0 1 0 0 1
crona M. crona c cr cro cron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .//.......-. 12 9 0 1 0 0 1
37. Eckert 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,.,.,..,- 12 9 0 1 0 0 1
er K., er e er er er BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 10 6 .,..//...... 12 9 0 1 0 0 1
P. 21-32. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .-. 3 1 0 1 0 0 1
38. Yamashita 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ..,.,.,., 9 9 0 1 0 0 1
V.L., Ninkina v.l., V V. V.L V.L. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,.,..,.,., 12 8 0 1 0 0 1
Hasegawa M. hasegawa H Ha Has Hase BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 .//......-. 11 9 0 1 0 0 1
39. Kukharsky 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,..,..,- 11 9 0 1 0 0 1
nikov R.K., nikov n ni nik niko BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,..,- 10 8 0 1 0 0 1
vitsky E. vitsky v vi vit vits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,..,..// 13 9 0 1 0 0 1
Pathogenesis. 2013. pathogenesis. P Pa Pat Path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ......-.(.). 12 8 0 1 0 0 1
40. Khritankova 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,..,..,- 11 8 0 1 0 0 1
churin S.O., churin c ch chu chur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..//.... 11 9 0 1 0 0 1
V. 446. v. V V. V. V. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ...-. 5 3 0 1 0 0 1
41. Steele 41. 4 41 41. 41. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,.,..,.,., 13 9 0 1 0 0 1
Kim S.H., kim K Ki Kim Kim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 ..,..,..,.,., 13 9 0 1 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .//.......-. 12 8 0 1 0 0 1
42. Bharadwaj 42. 4 42 42. 42. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ...,.,..,., 11 9 0 1 0 0 1
J.W., Lachenmayer j.w., J J. J.W J.W. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ..,..,.,..,., 13 9 0 1 0 0 1
S., et s., S S. S., S., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 .,.//.......-. 14 9 0 1 0 0 1
43. Kumar 43. 4 43 43. 43. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 ..,.,.,.,.,- 12 9 0 1 0 0 1
san M.I. san s sa san san BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 ..//........-. 14 9 0 1 0 0 1

